Warning: Undefined array key 0 in /var/www/hoodb/function.php on line 154

Warning: Trying to access array offset on value of type null in /var/www/hoodb/function.php on line 154

C₂N Diagnostics, LLC Announces Investment From Eisai Inc.

2024-05-03 19:09:11 | エーザイ

You are leaving and open the following URL" of about "エーザイ" news

news.google.com/rss/articles/CBMieWh0dHBzOi8vd3d3LmJ1c2luZXNzd2lyZS5jb20vbmV3cy9ob21lLzIwMjQwMzA2NDI3OTc5L2VuL0MlRTIlODIlODJOLURpYWdub3N0aWNzLUxMQy1Bbm5vdW5jZXMtSW52ZXN0bWVudC1Gcm9tLUVpc2FpLUluYy7SAQA?oc=5

Continue Opne >

エーザイ: C₂N Diagnostics, LLC Announces Investment From Eisai Inc.

More エーザイ news:

2024-04-01 07:00 Eisai, Biogen's subQ Leqembi delayed amid FDA's data request - FiercePharma
2024-04-18 19:08 With support from Eisai, Mission Based Media launches Alzheimer's podcast series - MM+M Online
2024-03-22 07:00 EU regulator delays decision on Eisai-Biogen Alzheimer's drug - Reuters.com
2024-04-11 07:00 Medicare estimates $3.5 billion cost on Alzheimer's drug Leqembi - STAT
2024-04-01 07:00 Biogen and Eisai Fall Behind on Leqembi’s Subcutaneous BLA for Alzheimer’s - BioSpace
2024-04-01 07:00 Eisai and Biogen move to bring IV maintenance dosing for Leqembi to the US - Pharmaceutical Technology
2024-03-06 08:00 Eisai to drop up to $15M on C2N Diagnostics to boost the reach of Alzheimer's disease blood tests - Fierce Biotech
2024-04-04 07:00 Eisai seeks FDA approval of Leqembi IV maintenance dosing - Alzheimer's News Today
2024-03-26 07:00 CHMP to Delay Nod on Biogen (BIIB), Eisai's Alzheimer's Drug - Yahoo Finance

2024-01-10 08:00 Eisai harnesses wearables data for AI-led Alzheimer's prediction - Mobihealth News
2023-10-25 07:00 Eisai Presents New LEQEMBI® (lecanemab-irmb) Investigational Subcutaneous Formulation Interim Study Results and ... - Biogen
2024-04-12 15:58 Eisai supports creation of Alzheimer's podcast miniseries - FiercePharma
2024-03-07 08:00 Japan's Eisai says US introduction of Alzheimer's drug Leqembi slower than expected - Reuters.com
2024-04-02 07:00 Eisai signs agreement to divest rights for two therapies to Kaken - Pharmaceutical Technology
2024-02-07 08:00 Eisai to Likely Miss Patient Goal for Leqembi by End of March 2024 - BioSpace
2024-04-05 07:00 Eisai, Carvykti, Ozempic biosimilar—Fierce Pharma Asia - FiercePharma
2024-02-05 08:00 Exclusive: Eisai expects 1500 Alzheimer's patients in China launch, sees 'huge' growth - Reuters.com
2024-03-08 08:00 Fierce Pharma Asia—Eisai's Leqembi outlook; Sumitomo's downsizing; Kyowa Kirin's expansion - FiercePharma
2024-01-09 08:00 China approves Alzheimer's treatment Leqembi by Eisai and Biogen - Reuters.com

2024-02-27 08:00 Neurologists paint bleak Leqembi launch picture as Alzheimer's drug trips up on a host of challenges - FiercePharma
2024-04-14 20:41 It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start? - The Columbian
2024-03-07 08:00 Despite Leqembi's launch pains, Eisai projects Alzheimer's med will reach $8.8B in the long run - FiercePharma
2023-12-13 08:00 Eisai to launch Alzheimer's drug Leqembi in Japan on Dec 20 - Reuters.com
2023-10-26 07:00 Injected version of Eisai/Biogen Alzheimer's drug works as well as IV Leqembi - Reuters.com
2023-10-24 07:00 Eisai & Biogen Leqembi: The 200 Best Inventions of 2023 - TIME
2023-08-25 07:00 Merck, Eisai discontinue late-stage study for combo cancer therapy - Reuters.com
2023-12-08 08:00 Merck-Eisai's endometrial cancer therapy combo fails first-line treatment trial - Reuters.com
2024-03-08 08:00 Eisai Details Continued Leqembi Development Plans, Including New Dosing, Delivery Methods - Precision Medicine Online
2024-03-07 08:00 Japan's Eisai to invest in U.S. Alzheimer's blood testing firm C2N - Nikkei Asia

2024-02-07 08:00 Eisai's Leqembi rollout moves slower than expected - FiercePharma
2023-11-08 08:00 Eisai Sees ‘Dramatic’ Increase in Leqembi Uptake Following Full FDA Approval - BioSpace
2024-02-01 08:00 After Eisai retirement, Ivan Cheung is back to lead Massachusetts biotech - Fierce Biotech
2023-10-25 07:00 Under-the-skin injection of Eisai's Leqembi is as effective as IV infusion, new Alzheimer's data show - STAT
2024-03-19 07:00 Why Eisai is one of the most innovative medicines and therapeutics companies of 2024 - Fast Company
2024-03-07 08:00 SA e-health startup RecoMed secures funding from Japanese pharma Eisai - - Disrupt Africa
2023-10-25 07:00 Biogen and Eisai release new Alzheimer’s drug data that may support wider uptake - MarketWatch
2023-09-25 07:00 Japan approves Alzheimer's treatment Leqembi by Eisai and Biogen - Reuters.com
2023-12-08 08:00 MSD's Keytruda and Eisai's Lenvima fail in Phase III uterine cancer trial - Pharmaceutical Technology
2024-02-02 08:00 Ex-Eisai leader Ivan Cheung to be new NextPoint CEO—Chutes & Ladders - Fierce Biotech

2024-02-16 08:00 No Playbook For Leqembi Eisai's Long Game In Alzheimer's Disease - Life Science Leader Magazine
2023-11-06 08:00 Eisai Shares Drop on Outlook Even With Alzheimer's Drug Sales - Bloomberg
2023-10-25 07:00 Eisai Alzheimer Drug Shows Promise in Injectable-At-Home Version - Bloomberg
2023-10-26 07:00 Eisai, Biogen Build Case for Subcutaneous Leqembi for Alzheimer’s at CTAD - BioSpace
2023-07-07 07:00 US FDA grants standard approval of Eisai/Biogen Alzheimer's drug - Reuters.com
2024-02-13 08:00 Roivant's risky Hemavant bet to wind down after discontinuing ex-Eisai drug - Fierce Biotech
2023-11-07 08:00 Eisai expects Alzheimer's drug to rake in revenue of $66.5 million by March - Yahoo Finance
2023-10-26 07:00 Eisai reporting positive data on injectable Alzheimer's drug - Yahoo Finance
2023-09-25 07:00 Merck, Eisai Post Back-to-Back Phase III NSCLC Failures for Keytruda-Lenvima Combo - BioSpace
2023-12-08 08:00 Merck and Eisai's Keytruda-Lenvima combo comes up short yet again, this time in endometrial cancer - FiercePharma

2024-03-11 07:00 Pharma company Eisai backs South African health tech venture RecoMed - ImpactAlpha
2024-03-06 08:00 C₂N Diagnostics, LLC Announces Investment From Eisai Inc. - Business Wire
2023-09-13 07:00 Eisai launches Theoria to build out a 'dementia ecosystem' - FiercePharma
2023-12-22 08:00 Eisai seeks expanded use of Alzheimer's drug for prevention - Nikkei Asia
2023-12-20 08:00 EpiVax Licenses ISPRI Toolkit to Eisai for Preclinical in silico Immunogenicity Screening APAC - English - PR Newswire
2023-06-09 07:00 US FDA panel backs approval for Eisai-Biogen Alzheimer's drug Leqembi - Reuters.com
2024-01-10 08:00 BioArctic AB and Eisai's Leqembi receives approval in China - Pharmaceutical Technology
2024-03-22 07:00 EU regulator delays decision on Eisai-Biogen Alzheimer's drug - Yahoo! Voices
2023-09-14 07:00 Japanese pharma Eisai forms digital dementia support biz - Mobihealth News
2023-10-26 07:00 Eisai, Biogen's injectable Leqembi clears toxic protein in Alzheimer's disease. What about safety? - FiercePharma

2024-02-22 08:00 Ligand Partner Eisai Receives Approval in Japan for Injection Formulation of Antiepileptic Drug Fycompa® - Business Wire
2023-11-16 08:00 Eisai And Eli Lilly Triumph At The 19th Annual Scrip Awards :: Scrip - Scrip
2024-02-28 08:00 EISAI TO PRESENT DATA ON LECANEMAB and OTHER ALZHEIMER'S DISEASE RESEARCH AT THE AD/PD ... - Yahoo Finance
2023-06-09 07:00 FDA panel unanimously endorses Eisai's Alzheimer's drug - STAT
2023-10-27 07:00 BioArctic and Eisai announce new positive data for SC versus IV Leqembi study - Clinical Trials Arena
2023-12-13 08:00 Eisai-Biogen Alzheimer's therapy to cost 2.98 million yen per year - Kyodo News Plus
2023-07-11 07:00 Eisai appoints CEO's son to lead global Alzheimer drug program - The Japan Times
2023-07-11 07:00 Eisai executive who helped lead development of Alzheimer's drug to retire - STAT
2023-07-10 07:00 Eisai Appoints CEO's 34-Year-Old Son to Lead Global Alzheimer Drug Program - Bloomberg
2023-10-26 07:00 Recon: Eisai's injectable version of Alzheimer's drug Leqembi as effective as infusion; J&J weighs bankruptcy as it ... - Regulatory Focus

2023-08-25 07:00 Merck, Eisai Drop Phase III Keytruda-Lenvima Trial for Head and Neck Cancer - BioSpace
2023-09-25 07:00 Japan's Eisai to boost sales staff to focus on new Alzheimer's drug - Nikkei Asia
2023-06-09 07:00 Eisai, Biogen's Leqembi passes muster at FDA adcomm - FiercePharma
2023-07-07 07:00 Biogen, Eisai stocks fall despite receiving FDA approval for Alzheimer's drug - Yahoo Finance
2023-07-22 07:00 Eisai eyes 2024 launch of trials for new Alzheimer's drug - Nikkei Asia
2023-08-25 07:00 Another Keytruda-Lenvima ambition is dashed as Merck, Eisai end head and neck cancer trial - FiercePharma
2023-08-24 07:00 Eisai, Merck & Co.'s Lenvima Patent Clashes Down to Validity - Bloomberg Law
2023-09-26 07:00 Eisai's regulatory progress brings cash flow for BioArctic - BioStock - Connecting Innovation and Capital
2023-07-07 07:00 Leqembi, Eisai Alzheimer’s Drug, Gets Full US Approval and Will See Wider Access - Bloomberg
2023-06-09 07:00 FDA Adcomm Unanimously Backs Full Approval of Eisai, Biogen’s Leqembi - BioSpace

2023-07-18 07:00 New Alzheimer's drug success 'was built on failures': Eisai exec - Yahoo Finance
2023-07-07 07:00 Japanese pharma Eisai slides 4% despite FDA approval for Alzheimer's drug - CNBC
2023-07-06 07:00 Eisai, Biogen snag full, traditional approval for Alzheimer's med Leqembi - FiercePharma
2023-07-06 07:00 FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage - CNBC
2023-07-07 07:00 Biogen, Eisai Alzheimer's drug gets full approval, but faces slow uptake - Yahoo Finance
2023-09-25 07:00 Japan approves Alzheimer's drug developed by Eisai, Biogen - Kyodo News Plus
2023-09-22 07:00 Merck and Eisai's Keytruda-Lenvima combo chalks up 2 more losses, this time in non-small cell lung cancer - FiercePharma
2023-07-11 07:00 Eisai's US CEO and Alzheimer's lead Ivan Cheung telegraphs retirement days after Leqembi's full FDA nod - FiercePharma
2023-06-29 07:00 Eisai launches Gates-backed research collab to develop digital tools for dementia diagnosis, treatment - Fierce Biotech
2023-06-07 07:00 Japanese pharma giant Eisai working with law enforcement to resolve ransomware attack - The Record from Recorded Future News

2023-07-13 07:00 Leqembi gets positive feedback from experts: analysts - FiercePharma
2023-06-06 07:00 Eisai hit with ransomware attack, launches investigation into possible data leaks - FiercePharma
2023-09-13 07:00 Eisai launches new digital business company for dementia - PharmaTimes - PharmaTimes
2023-07-06 07:00 Eisai and Biogen Alzheimer's drug lecanemab receives approval from FDA - USA TODAY
2023-07-07 07:00 Companies in Alzheimer's race after US nod for Eisai/Biogen drug - Reuters.com
2023-07-07 07:00 Eisai-Biogen Alzheimer's drug receives full U.S. approval - Nikkei Asia
2023-07-21 07:00 Eisai, Astellas, GSK and more—Fierce Pharma Asia - FiercePharma
2023-09-30 07:34 No Fast Track For Lecanemab In EU Disappoints Eisai - Pink Sheet
2023-06-10 07:00 Eisai-Biogen Alzheimer's drug backed for full U.S. approval - Nikkei Asia

About エーザイ

2024-05-03 from us

Warning: file_get_contents(aCache/search/us/エーザイ): Failed to open stream: No such file or directory in /var/www/hoodb/function.php on line 340

エーザイ, C₂N Diagnostics, LLC Announces Investment From Eisai Inc. 2022 エーザイ

C₂N Diagnostics, LLC Announces Investment From Eisai Inc.

Choose Your Country or Region

C₂N Diagnostics, LLC Announces Investment From Eisai Inc.